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Abstract 
Primary pancreatic lymphoma (PPL) is a rare tumor that usually presents with the clinical 
picture of advanced adenocarcinoma but has a much better prognosis. A 38-year-old 
man was referred after percutaneous transhepatic external biliary drainage for 
obstructive jaundice. Abdominal magnetic resonance imaging (MRI) and magnetic 
resonance cholangiopancreatography had revealed a 5-cm pancreatic head mass that 
caused biliary tract dilation. Computed tomography angiography showed that the mass 
encased the celiac trunk as well as the common hepatic and splenic arteries. MRI also 
revealed a metastatic lesion at the third lumbar vertebra. Serum carcinoembryonic 
antigen and carbohydrate antigen 19-9 levels were within normal range. The initial 
diagnosis was inoperable pancreatic adenocarcinoma; however, Tru-Cut pancreatic 
biopsy showed a large B cell lymphoma. After 6 sessions of chemotherapy and 
21 sessions of radiotherapy, both the pancreatic mass and the vertebral metastasis had 
disappeared. However, he had persistent distal common bile duct stricture that could 
not be negotiated by either the endoscopic or percutaneous route. A Roux-en-Y 
hepaticojejunostomy was performed. The patient stayed alive without recurrence for 
52 months after the initial diagnosis and 45 months after completion of oncologic 
treatment. In conclusion, a large pancreatic mass with grossly involved peripancreatic 
lymph nodes, without ascites, liver or splenic metastasis, should alert the clinician to the 
possibility of PPL. Cure is possible by chemoradiotherapy even in the presence of Case Rep Gastroenterol 2011;5:642–647 
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vertebral metastasis. Persistent stricture in the distal common bile duct may require a 
biliodigestive anastomosis. 
Introduction 
Primary pancreatic lymphoma (PPL) is a rare cause of obstructive jaundice. Baylor and 
Berg reported the incidence of PPL as <0.5% in their pathology series of 5,000 pancreatic 
tumors [1]. A review of the literature between 1951 and 1999 included 122 patients [2], a 
more recent review compiled 11 series published between 1985 and 2005 and included 
103 patients; 4 other patients were reported from the reviewers’ institution [3]. In 
comparison with most of the other pancreatic malignancies, PPL has much more 
favorable survival after aggressive treatment [4, 5]. Herein, we present a primary 
pancreatic non-Hodgkin lymphoma patient with vertebral column metastasis, cured by 
combined chemoradiotherapy. Persistent biliary stricture in the distal common bile duct 
required a Roux-en-Y hepaticojejunostomy. 
Case Report 
A 38-year-old man was referred with the presumptive diagnosis of inoperable pancreatic head 
carcinoma; he had undergone percutaneous transhepatic biliary drainage for obstructive jaundice. 
Physical examination showed no pathological findings except jaundice. Biochemical results were as 
follows: total bilirubin 8.7 mg/dl (0.2–1.0), direct bilirubin 7.4 mg/dl (0–0.3), alkaline phosphatase 
585 U/l (30–130), aspartate aminotransferase 81 U/l (5–42), alanine aminotransferase 97 U/l (5–45), 
gamma-glutamyl transpeptidase 268 U/l (5–85). The serum carcinoembryonic antigen and 
carbohydrate antigen 19-9 levels were within normal limits – 2.4 ng/ml (0.0–4.0) and 13.8 U/ml  
(0–34.0), respectively. 
Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography performed 
at the referring institution before biliary drainage had revealed a 5-cm diameter pancreatic head mass 
causing biliary tract dilation. MRI also showed a metastatic lesion at the corpus of the L3 vertebra. 
Computed tomography (CT) angiography showed that the pancreatic head mass encased the celiac 
trunk as well as the common hepatic and splenic arteries (fig. 1). Tru-Cut biopsy of the pancreatic mass 
revealed a non-Hodgkin lymphoma of the diffuse large B cell type; there was diffuse neoplastic 
infiltration on a sclerotic background. The results of immunohistochemistry were as follows: CD3 (–), 
CD20 (+), pancytokeratin (–), synaptophysin (–), chromogranin A (–), mum-1 (–), bcl-6 (+) and 
leukocyte common antigen (LCA) (+) (fig. 2). He was referred to the oncology clinic. Both lesions 
disappeared completely after 6 sessions of chemotherapy (CHOP, cyclophosphamide, adriamycin, 
vincristine, prednisone) and 21 sessions of external beam radiotherapy (fig. 3). However, the stricture 
in the distal common bile duct persisted. Since a guide wire could not be negotiated through the 
stricture either by the transhepatic or endoscopic route (3 attempts), internal drainage was not achieved. 
Acute cholecystitis developed and was treated by percutaneous drainage. A positron emission 
tomography-computed tomography (PET-CT) was performed for possible residual or recurrent disease; 
however, no evidence of malignancy was detected. The patient underwent surgery for persistent biliary 
stricture. The gallbladder wall was thickened and edematous. There were multiple enlarged lymph 
nodes at the hepatoduodenal ligament, but there was no mass at the head of the pancreas. Frozen 
section examination of the lymph nodes as well as subsequent paraffin section examination showed no 
sign of lymphoma. The presumptive diagnosis was a fibrotic stricture caused by chronic pressure or 
radiotherapy. Cholecystectomy and Roux-en-Y hepaticojejunostomy were performed.  
The patient stayed alive without local or systemic recurrence of the disease for 52 months after the 
initial diagnosis and 45 months after completion of oncologic treatment. Case Rep Gastroenterol 2011;5:642–647 
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Discussion 
The clinical and diagnostic criteria for PPL were initially proposed by Dawson et al. [4] 
and subsequently modified by Behrns et al. [6]: a mass predominantly within the pancreas 
with grossly involved lymph nodes confined to the peripancreatic area, no peripheral 
lymphadenopathy, no hepatic or splenic involvement, no mediastinal lymphadenopathy, 
and a normal white blood cell count. The patient presented above fulfilled these criteria.  
The most common symptom is abdominal pain [6]. PPL is usually seen at the head 
of the pancreas; a mass at the tail or body or diffuse infiltration of the organ are rare 
presentations. Most of the reported tumors were >5 cm in diameter and involved the 
peripancreatic lymph nodes [7]. Approximately 35% of patients had obstructive jaundice 
like the patient presented here, but obstructive jaundice is less frequent in PPL than 
adenocarcinoma of the pancreas [5]. The classic symptoms of nodal non-Hodgkin 
lymphoma, such as fever, chills, and night sweats, are uncommon [5, 7]. Both CT and 
MRI demonstrate the tumor adequately, but the findings are not specific for lymphoma 
[5]. 
In short, there are no clinical or biochemical findings specific for pancreatic 
lymphoma, imaging studies are not pathognomonic and do not distinguish PPL 
from carcinoma. Consequently, most of the cases were diagnosed after surgery by 
histopathological determination of the resection or biopsy specimens [2, 6, 8]. A large 
pancreatic mass with grossly involved peripancreatic lymph nodes without ascites, liver 
or splenic metastasis should alert the clinician to the possibility of PPL [5]. 
Baylor and Berg reported the incidence of PPL as <0.5% in their pathology series [1], 
and Volmar et al. reported the incidence as 1.3% in their pancreatic fine-needle aspiration 
biopsy series [9]. The major disadvantage of fine-needle aspiration biopsy is that it may 
provide insufficient tissue for both histopathological diagnosis and immunohistochemical 
examination [9, 10]. In our institution, Tru-Cut biopsy was preferred. 
Non-Hodgkin lymphomas are staged according to the modified Ann Arbor 
classification. In this scheme, IE is disease confined to the pancreas, and IIE disease 
involves the peripancreatic lymph nodes [10]. The Revised European American 
Lymphoma classification is used for histological classification [11]. We classified our 
patient as IIE because of the possible involvement of the peripancreatic lymph nodes and 
non-Hodgkin lymphoma of the diffuse large B cell type. 
Approximately 10% of the metastatic vertebral tumors were found to be lymphomas 
[12]. The majority of cases of musculoskeletal lymphoma were caused by hematogenous 
dissemination of the nodal disease. Involvement of the skeleton is more likely in the axial 
bones than the appendages [12]. To the best of our knowledge, the patient in the present 
report is the first primary pancreas lymphoma case in the literature with vertebral 
metastasis. 
Resection of ‘small’ tumors with the presumptive diagnosis of periampullary 
carcinoma yields excellent results [2]. In current practice, preoperative biopsy of 
resectable pancreatic masses is rarely performed. In other words, the diagnosis of 
pancreatic lymphoma in the resection specimen is probably a postoperative diagnosis 
rather than a preoperative one. However, since most pancreatic lymphomas are bulky 
tumors that are unresectable at presentation, oncologic treatment is the only option. Case Rep Gastroenterol 2011;5:642–647 
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Successful results including cure rates up to 30% have been achieved with combined 
modality treatment [5]. Survival as long as 191 months with chemotherapy alone has been 
reported [13]. Long-term follow-up is vital because recurrences as late as 18 years have 
been encountered [13]. 
Although chemoradiotherapy achieved complete remission of the pancreatic and 
vertebral masses in our patient, there was a persistent biliary stricture. The differential 
diagnosis included obstruction caused by residual-recurrent tumor or secondary 
fibrosis caused by radiotherapy or chronic compression of the primary tumor [14]. 
CT angiography showed a short stenotic segment in the portal vein, but no recurrent 
mass was detected. CT combined fluoro-deoxy-D-glucose PET scan and gallium-67 
scintigraphy have been used to detect residual, metastatic or recurrent lymphoma 
and found to be superior to CT alone [15]. In the patient reported here, PET-CT and 
intraoperative observation showed no sign of residual or recurrent lymphoma. Benign 
strictures that persisted after complete remission with chemotherapy, and radiation-
induced late biliary strictures [14] were successfully treated with Roux-en-Y 
hepaticojejunostomy. The same approach was effective in our patient as well. 
In conclusion, a large pancreatic mass with grossly involved peripancreatic lymph 
nodes, but without ascites, liver or splenic metastasis, should alert the clinician to the 
possibility of PPL. Cure is possible by chemoradiotherapy even in the presence of 
vertebral metastasis. Persistent stricture in the distal common bile duct may require a 
biliodigestive anastomosis. 
 
 
 
 
 
 
Fig. 1. The pancreatic head mass encased the celiac trunk as well as the common hepatic and splenic 
arteries. 
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Fig. 2. Pathological examination of the Tru-Cut biopsy. 
 
 
 
Fig. 3. CT angiography examination 45 months after completion of oncologic treatment. 
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